ROMOSOZUMAB 105 MG / 1.17ML INJ (PACK OF 2PFS)
Directorate of Purchase and Stores · Pharmaceuticals · open
Key facts
- Published: 02 Sep 2026
- Closing date: 24 Sep 2026
- Status: open
- Department: Department of Atomic Energy
- Office: Directorate of Purchase and Stores
Description
Tender for supply of ROMOSOZUMAB 105 MG / 1.17ML INJ (PACK OF 2PFS) with a total quantity of 15 units, issued by the Department of Atomic Energy, Directorate of Purchase and Stores. Bid validity is 90 days from the end date, with bid opening scheduled for 24-09-2026 at 14:30. The tender includes technical specifications, eligibility criteria, and purchase preferences for MSEs and startups.
Eligibility & requirements
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Turnover Criteria, Experience Certificates, Quality and Technical Specifications
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Packet Bid
- Evaluation: value wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (1)
- ROMOSOZUMAB 105 MG / 1.17ML INJ (PACK OF 2PFS) — Qty: 15 unit
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals